TCR2 Therapeutics Inc.
TCRRDelisted Jun 1, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001750019
TCR2 Therapeutics Inc. was delisted on Jun 1, 2023; its insiders filed their last Form 4 on Feb 14, 2024; 59 institutions reported holding it in 13F filings for Q1 2023, worth $31.5M in total; no superinvestor held it.
13F holders, Q2 2021
Institutional positions in TCR2 Therapeutics Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 119
- −10 vs. Q1 2021
- Shares held
- 35.1M
- −2.61M (−6.9%) vs. Q1 2021
- Total value
- $575.3M
- −$259.4M (−31.1%) vs. Q1 2021
- New holders
- 13
- 49 more added
- Sold out
- 23
- 34 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TCRR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 59 | $31.5M |
| Q4 2022 | 63 | $21.2M |
| Q3 2022 | 81 | $45.1M |
| Q2 2022 | 83 | $72.2M |
| Q1 2022 | 94 | $74.8M |
| Q4 2021 | 122 | $136.0M |
| Q3 2021 | 117 | $271.1M |
| Q2 2021 | 119 | $575.3M |
| Q1 2021 | 129 | $834.8M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding TCR2 Therapeutics Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Northern Trust Corp | 331,163 | $5.43M | 0.00% | +1,738+0.5% | Added |
| Citadel Advisors LLC | 379,996 | $6.24M | 0.01% | −209,555−35.5% | Reduced |
| FMR LLC | 424,800 | $6.97M | 0.00% | −33,900−7.4% | Reduced |
| Dimensional Fund Advisors LP | 445,815 | $7.32M | 0.00% | +95,131+27.1% | Added |
| Cormorant Asset Management, LP | 479,506 | $7.87M | 0.31% | −420,494−46.7% | Reduced |
| Geode Capital Management, LLC | 491,836 | $8.07M | 0.00% | +36,526+8.0% | Added |
| First Light Asset Management, LLC | 644,216 | $10.6M | 0.63% | −182,258−22.1% | Reduced |
| JPMorgan Chase & Co | 659,411 | $10.8M | 0.00% | +4,597+0.7% | Added |
| Rothschild & Co Asset Management US Inc. | 690,274 | $11.3M | 0.13% | +131,563+23.5% | Added |
| Artal Group S.A. | 750,000 | $12.3M | 0.28% | 00.0% | Unchanged |
| Candriam Luxembourg S.C.A. | 934,551 | $15.3M | 0.10% | +540,263+137.0% | Added |
| ArrowMark Colorado Holdings LLC | 1,027,128 | $16.9M | 0.13% | +63,522+6.6% | Added |
| Vanguard Group Inc | 1,389,360 | $22.8M | 0.00% | +17,857+1.3% | Added |
| State Street Corp | 2,231,224 | $36.6M | 0.00% | +42,870+2.0% | Added |
| BlackRock Inc. | 2,937,118 | $48.2M | 0.00% | −129,518−4.2% | Reduced |
| Redmile Group, LLC | 3,235,809 | $53.1M | 0.79% | −374,979−10.4% | Reduced |
| MPM Oncology Impact Management LP | 3,370,982 | $55.3M | 9.09% | 00.0% | Unchanged |
| MPM Asset Management LLC | 4,050,865 | $66.5M | 12.36% | 00.0% | Unchanged |
| Wellington Management Group LLP | 5,334,338 | $87.5M | 0.01% | +398,244+8.1% | Added |
| Marshall Wace North America L.P. | 0 | $0 | 0.00% | −503,860−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −249,279−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −136,486−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −112,795−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −51,700−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −46,940−100.0% | Sold out |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 0 | $0 | 0.00% | −39,577−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −29,775−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −22,211−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −18,781−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −17,995−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −16,384−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −13,500−100.0% | Sold out |
| Allstate Corp | 0 | $0 | 0.00% | −9,402−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −9,448−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −9,069−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −2,705−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −1,119−100.0% | Sold out |
| International Assets Investment Management, LLC | 0 | $0 | 0.00% | −1,150−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Manchester Financial Inc | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −50−100.0% | Sold out |